Inbal Houri

848 total citations · 2 hit papers
14 papers, 543 citations indexed

About

Inbal Houri is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Inbal Houri has authored 14 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in Inbal Houri's work include SARS-CoV-2 and COVID-19 Research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis C virus research (4 papers). Inbal Houri is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis C virus research (4 papers). Inbal Houri collaborates with scholars based in Israel, Finland and Canada. Inbal Houri's co-authors include Oren Shibolet, Helena Katchman, Tami Halperin, Roni Baruch, Liane Rabinowich, Eugene Katchman, Dan Turner, Ayelet Grupper, Merav Ben‐Yehoyada and Sharon Levi and has published in prestigious journals such as Journal of Hepatology, International Journal of Environmental Research and Public Health and American Journal of Transplantation.

In The Last Decade

Inbal Houri

13 papers receiving 534 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

2021 242 citations Ayelet Grupper, Liane Rabinowich et al. American Journal of Transplantation profile →
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients

2021 226 citations Liane Rabinowich, Ayelet Grupper et al. Journal of Hepatology profile →

Peers

Inbal Houri

ASZ

HEALT

EPIDE

Michael T. Ou United States

Jonas Hillebrandt Germany

Sandra Hauka Germany

Tina Marinelli Australia

Shi Yin Wong Singapore

Timna Agur Israel

Noëlle Cognard France

Louise Benning Germany

Yorg Azzi United States

Wiebke Moskorz Germany

Michael T. Ou United States

Inbal Houri

418 ×0.9

120 ×1.0

98 ×1.0

ASZ

85 ×0.9

HEALT

41 ×0.6

EPIDE

Citations per year, relative to Inbal Houri Inbal Houri (= 1×) peers Michael T. Ou

Countries citing papers authored by Inbal Houri

Since Specialization

Citations

This map shows the geographic impact of Inbal Houri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inbal Houri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inbal Houri more than expected).

Fields of papers citing papers by Inbal Houri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inbal Houri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inbal Houri. The network helps show where Inbal Houri may publish in the future.

Co-authorship network of co-authors of Inbal Houri

This figure shows the co-authorship network connecting the top 25 collaborators of Inbal Houri. A scholar is included among the top collaborators of Inbal Houri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inbal Houri. Inbal Houri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Houri, Inbal & Gideon M. Hirschfield. (2023). Primary Biliary Cholangitis. Clinics in Liver Disease. 28(1). 79–92. 11 indexed citations

Grupper, Ayelet, Liane Rabinowich, Merav Ben‐Yehoyada, et al.. (2022). Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients. Transplantation Proceedings. 54(6). 1439–1445. 7 indexed citations

Rabinowich, Liane, Sharon Levi, Inbal Houri, et al.. (2022). Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus. International Journal of Environmental Research and Public Health. 19(22). 15237–15237. 3 indexed citations

Rabinowich, Liane, Ayelet Grupper, Inbal Houri, et al.. (2022). Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients. Journal of Hepatology. 77. S790–S791.

Fishman, Sigal, Minna Holopainen, Reijo Käkelä, et al.. (2021). Repetitive amiodarone administration causes liver damage via adipose tissue ER stress-dependent lipolysis, leading to hepatotoxic free fatty acid accumulation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 321(3). G298–G307. 15 indexed citations

Rabinowich, Liane, Ayelet Grupper, Roni Baruch, et al.. (2021). Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. Journal of Hepatology. 75(2). 435–438. 226 indexed citations breakdown →

Grupper, Ayelet, Liane Rabinowich, Doron Schwartz, et al.. (2021). Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. American Journal of Transplantation. 21(8). 2719–2726. 242 indexed citations breakdown →

Houri, Inbal, et al.. (2021). Real-World Management of Patients with Primary Biliary Cholangitis—A Retrospective Study from a Tertiary Medical Center in Israel. Journal of Clinical Medicine. 10(19). 4551–4551. 4 indexed citations

Grupper, Ayelet, Eugene Katchman, Merav Ben‐Yehoyada, et al.. (2021). Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine. Clinical Transplantation. 35(12). e14478–e14478. 22 indexed citations

10.

Houri, Inbal, Ziv Ben‐Ari, Amir Shlomai, et al.. (2020). Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial. BMC Infectious Diseases. 20(1). 264–264. 5 indexed citations

11.

Houri, Inbal, et al.. (2020). Emergency department targeted screening for hepatitis C does not improve linkage to care. World Journal of Gastroenterology. 26(32). 4878–4888. 5 indexed citations

12.

Houri, Inbal, et al.. (2020). Emergency department screening for hepatitis C carriers does not improve linkage to care - a single-center prospective study. Journal of Hepatology. 73. S315–S316. 1 indexed citations

13.

Houri, Inbal, et al.. (2015). Implementation of guidelines for metabolic syndrome control in kidney transplant recipients: results at a single center. Diabetology & Metabolic Syndrome. 7(1). 90–90. 1 indexed citations

14.

Merhav, Hadar, Richard Nakache, Inbal Houri, & Ruth Orni‐Wasserlauf. (2001). Liposomal amphotericin B (Ambisome) is safe and effective in the treatment of invasive mycosis in organ transplant patients. Transplantation Proceedings. 33(6). 2937–2938. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact